United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded May 7, 2026 · Filed May 7, 2026

On May 7, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$586.75 for US$4.87M under a trading plan, leaving 45,172 shares. Filed May 7, 2026 (Form 4).

Sold
8,300 shares
Price
US$586.75 average (US$582.86 to US$597.54)
Value
US$4.87M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 7, 2026Common StockOption exercise8,300US$146.0353,472Direct
May 7, 2026Common StockSale80US$582.8653,392Direct
May 7, 2026Common StockSale1,475US$584.0751,917Direct
May 7, 2026Common StockSale994US$585.1850,923Direct
May 7, 2026Common StockSale1,689US$586.1749,234Direct
May 7, 2026Common StockSale2,970US$587.6146,264Direct
May 7, 2026Common StockSale820US$588.5145,444Direct
May 7, 2026Common StockSale70US$596.1945,374Direct
May 7, 2026Common StockSale202US$597.5445,172Direct

Source

View original at SEC

Related